OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection
Salma Sheikh‐Mohamed, Baweleta Isho, Gary Chao, et al.
Mucosal Immunology (2022) Vol. 15, Iss. 5, pp. 799-808
Open Access | Times Cited: 227

Showing 1-25 of 227 citing articles:

SARS-CoV-2 viral load and shedding kinetics
Olha Puhach, Benjamin Meyer, Isabella Eckerle
Nature Reviews Microbiology (2022)
Open Access | Times Cited: 324

Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
Jinyi Tang, Cong Zeng, Thomas M Cox, et al.
Science Immunology (2022) Vol. 7, Iss. 76
Open Access | Times Cited: 278

Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
Tianyang Mao, Benjamin Israelow, Mario A. Peña-Hernández, et al.
Science (2022) Vol. 378, Iss. 6622
Open Access | Times Cited: 253

Correlates of protection against SARSCoV‐2 infection and COVID‐19 disease
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 244

Immunological memory to SARS‐CoV ‐2 infection and COVID ‐19 vaccines
Alessandro Sette, Shane Crotty
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 27-46
Open Access | Times Cited: 218

SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
Kaori Sano, Disha Bhavsar, Gagandeep Singh, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 126

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
Felicity Liew, Shubha Talwar, Andy Cross, et al.
EBioMedicine (2022) Vol. 87, pp. 104402-104402
Open Access | Times Cited: 93

Operation Nasal Vaccine—Lightning speed to counter COVID-19
Eric J. Topol, Akiko Iwasaki
Science Immunology (2022) Vol. 7, Iss. 74
Closed Access | Times Cited: 82

Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report
Jane M. Knisely, Lucas E. Buyon, Rebecca Mandt, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 73

Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters
Geraldine Nouailles, Julia M. Adler, Peter Pennitz, et al.
Nature Microbiology (2023) Vol. 8, Iss. 5, pp. 860-874
Open Access | Times Cited: 65

Mucosal vaccines for SARS-CoV-2: triumph of hope over experience
Devaki Pilapitiya, Adam K. Wheatley, Hyon‐Xhi Tan
EBioMedicine (2023) Vol. 92, pp. 104585-104585
Open Access | Times Cited: 50

SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase
Komal Srivastava, Juan Manuel Carreño, Charles Gleason, et al.
Immunity (2024) Vol. 57, Iss. 3, pp. 587-599.e4
Open Access | Times Cited: 45

Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages
Harold Marcotte, Yunlong Cao, Fanglei Zuo, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 3
Open Access | Times Cited: 25

Vaccine Strategies to Elicit Mucosal Immunity
Yufeng Song, Frances Mehl, Steven L. Zeichner
Vaccines (2024) Vol. 12, Iss. 2, pp. 191-191
Open Access | Times Cited: 24

mRNA vaccines for infectious diseases — advances, challenges and opportunities
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 23

Lipid nanoparticles for local delivery of mRNA to the respiratory tract: Effect of PEG-lipid content and administration route
Melike Ongun, Abhijeet Lokras, Saahil Baghel, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 198, pp. 114266-114266
Open Access | Times Cited: 21

A humanized mouse that mounts mature class-switched, hypermutated and neutralizing antibody responses
Daniel P. Chupp, Carlos Eduardo Rivera, Yulai Zhou, et al.
Nature Immunology (2024) Vol. 25, Iss. 8, pp. 1489-1506
Open Access | Times Cited: 18

Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6

Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications
Ming Zhou, Haihua Xiao, Xinyi Yang, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access | Times Cited: 2

Expansion of cytotoxic tissue-resident CD8+ T cells and CCR6+CD161+ CD4+ T cells in the nasal mucosa following mRNA COVID-19 vaccination
Aloysious Ssemaganda, Huong Mai Nguyen, Faisal Nuhu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 68

Instructing durable humoral immunity for COVID-19 and other vaccinable diseases
Deepta Bhattacharya
Immunity (2022) Vol. 55, Iss. 6, pp. 945-964
Open Access | Times Cited: 49

The role of vaccines in the COVID-19 pandemic: what have we learned?
Florian Krammer
Seminars in Immunopathology (2023) Vol. 45, Iss. 4-6, pp. 451-468
Open Access | Times Cited: 43

SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia
Marianna Karachaliou, Gemma Moncunill, Ana Espinosa, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 39

Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection
Béré Diallo, Caitlín Ní Chasaide, Ting Y. Wong, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 35

Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
Laura Pérez‐Alós, Cecilie Bo Hansen, José Juan Almagro Armenteros, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 33

Page 1 - Next Page

Scroll to top